Cor Vasa 2023, 65(3):563-566 | DOI: 10.33678/cor.2021.100

Sino-atrial block due to Guillan-Barré syndrome: a rare case

Giuseppe Pelaggia, Alfredo Luongoa, Francesca Parisia, Paolo Vinciguerraa, Alessia Pernaa, Federica Cocuzzaa, Francesca Campanellaa, Alessio Curròb, Lorenzo Pistelli
a Department of Clinical and Experimental Medicine, University of Messina, Italy
b Cardiac Intensive Care, Piemonte-Papardo Hospital, Messina, Italy

Sino-atrial node block is a condition characterized by a slowed (or interrupted) electrical impulse transmis- sion from the sino-atrial node to the atrium.1 The sino-atrial dysfunction potentially leads to sinusal arrest, bradycardia up to asystole, syncope and cardiac arrest. In such situations, a temporary or permanent pacemaker implantation is necessary. Different causes may be responsible for sinus atrial block, more frequently vagal hypertone, ions alterations, myocarditis and iatrogenic causes.2-9 We report the case of a sixty-year-old man with Guillain-Barré syndrome who required pacemaker implantation for II to III degree sino-atrial block and symptomatic pauses lasting 2.8 s.

Keywords: Guillain-Barré syndrome, Pacemaker, Sino-atrial block

Received: May 7, 2022; Revised: May 7, 2022; Accepted: August 17, 2023; Published: June 20, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pelaggi G, Luongo A, Parisi F, Vinciguerra P, Perna A, Cocuzza F, et al.. Sino-atrial block due to Guillan-Barré syndrome: a rare case. Cor Vasa. 2023;65(3):563-566. doi: 10.33678/cor.2021.100.
Download citation

References

  1. Oreto G, et al. I disordini del ritmo cardiaco, diagnosi delle aritmie cardiache all'elettrocardiogramma di superficie. 2010.
  2. Braunwald E, Mann DL, Zips DP, et al. Manuale del cuore di Braunwald. 2016
  3. Wojtaszczyk A, Buchta P, Myrda K, et al. Hybrid dual stage closed chest ablation of persistent atrial fibrillation. Cor Vasa 2017;59:e337-e344. Go to original source...
  4. Naydenov SN, Runev NM, Manov EI, et al. When is it too late for a correction of an atrial septal defect secundum type in an adult patient? Cor Vasa 2016;58:e439-e443. Go to original source...
  5. Patanè S, Marte F, Dattilo G, et al. Acute myocardial infarction and left bundle branch block with changing axis deviation. Int J Cardiol 2012;154:e47-e49. Go to original source...
  6. Casale M, Mezzetti M, Gigliotti De Fazio M, et al. Novel active fixation lead guided by electrical delay can improve response to cardiac resynchronization therapy in heart failure. ESC Heart Fail 2022;9:146-154. Go to original source...
  7. Kafes H, Açar B, Asarcikli L, et al. P-wave dispersion and atrial electromechanical delay in patients with inflammatory bowel disease. Cor Vasa 2019;61:459-463. Go to original source...
  8. Casale M, Correale M, Laterra G, et al. Effects of Sacubitril/Valsartan in Patients with High Arrhythmic Risk and an ICD: A Longitudinal Study. Clin Drug Investig 2021;41:169-176. Go to original source...
  9. Casale M, Mezzetti M, De Fazio MG, et al. Usefulness of Sacubitril/Valsartan in reduction of atrial fibrillation burden in a patient with ICD delivering inappropriate therapies. A new possibility? Cor Vasa 2020;62:336-339. Go to original source...
  10. Nguyen TP, Taylor RS. Guillain Barré Syndrome. 2021 Jul 10. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022 Jan.
  11. Walling AD, Dickson G. Guillain-Barré Syndrome. Am Fam Physician 2013;87:191-197. Go to PubMed...
  12. de Gregorio C, Laterra G, Vaccaro V, et al. Time-based clinical and functional achievements in real-life HF patients on ARNI treatment. Eur J Intern Med 2020;76:115-117. Go to original source...
  13. Van den Bergh PY, Hadden RD, Bouche P, et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - First Revision. Eur J Neurol 2010;17:356-363. Go to original source...
  14. Hahn AF. Guillain-Barré syndrome. Lancet 1998;352:635-664. Go to original source...
  15. Kimoto K, Koga M, Odaka M, et al. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies. Neurology 2006;67:1837-1843. Go to original source... Go to PubMed...
  16. Laníková M, Pařízek P, Hodač M. The neurocardiogenic response during the head-up tilt test in patients with permanent atrial fibrillation. Cor Vasa 2007;49:92-94. Go to original source...
  17. Flachenecker P, Wermuth P, Hartung HP, Reiners K. Quantitative assessment of cardiovascular autonomic function in Guillain-Barré syndrome. Ann Neurol 1997;42:171-179. Go to original source...
  18. Tuck RR, McLeod JG. Autonomic dysfunction in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1981;44:983-990. Go to original source...
  19. Jirmář R, Pěnička M, Moťovská Z, et al. Prognosis of patients with mechanical ventilation in the acute phase of myocardial infarction in the era of primary coronary intervention. Cor Vasa 2007;49:448-453. Go to original source...
  20. Patanè S, Marte F, Sturiale M, et al. Atrial flutter, ventricular tachycardia and changing axis deviation associated with scleroderma. Int J Cardiol 2011;153:e25-e28. Go to original source...
  21. Patanè S, Marte F, Dattilo G. Intermittent changing axis deviation during acute myocarditis. Int J Cardiol 2010;145:e13-e16. Go to original source...
  22. Dattilo G, Scarano M, Casale M, et al. An atypical manifestation of Twiddler syndrome. Int J Cardiol 2015;186:1-2. Go to original source...
  23. Patanè S, Marte F, Sturiale M, et al. Changing axis deviation and acute myocardial infarction. Int J Cardiol 2011;151:e1-e3. Go to original source...
  24. Bredin CP. Guillain-Barré syndrome: the unsolved cardiovascular problems. Ir J Med Sci 1977;146:273-279. Go to original source...
  25. Stojadinović P, Kettner J, Kautzner J.The less common arrhythmias in the acute cardiac care unit. Cor Vasa 2019;61:e323-e326. Go to original source...
  26. Yassin YN, Roubíček T, Lípa J, et al.Ventricular tachycardia as the first manifestation of cardiac sarcoidosis. Cor Vasa 2020;62:501-505. Go to original source...
  27. Mericle RA, Triggs WJ. Treatment of acute pandysautonomia with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 1997;62:529-531. Go to original source...
  28. Yoshii F, Kozuma R, Haida M, et al. Giant negative T waves in Guillain-Barré syndrome. Acta Neurol Scand 2000;101:212-215. Go to original source... Go to PubMed...
  29. Jukl L, Vondrák J, Kubrycht M, et al. The prognostic value of exercise stress echocardiography - validation of a newly implemented method in our center. Cor Vasa 2018;60:e615-e621. Go to original source...
  30. Dattilo G, Imbalzano E, Lamari A, et al. Ischemic heart disease and early diagnosis. Study on the predictive value of 2D strain. Int J Cardiol 2016;215:150-156. Go to original source...
  31. Dattilo G, Carerj S, Lamari A, et al. The chance finding at multislice computed tomography coronary angiography of myocardial bridging. Int J Cardiol 2012;154:e21-e23. Go to original source...
  32. Votavová R, Linhartová A, Kořínek J, et al. Echocardiography in coronary artery disease. Cor Vasa 2015;57:e408-e418. Go to original source...
  33. Imbalzano E, Saitta A, Lamari A, et al. Echo-Doppler evaluation of recent onset chronic venous insufficiency in elderly patients: does the heart have a role? Recenti Prog Med 2013;104:569-573.
  34. Unal O, Oztas DM, Beyaz MO, et al. Increased CRP/albumin ratio is associated with superficial venous reflux disease and varicose vein formation. Cor Vasa 2021;63:430-434. Go to original source...
  35. Lo Gullo A, Rodríguez-Carrio J, Aragona CO, et al. Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients:Association with vitamin D and inflammation. Atherosclerosis 2018;271:214-222. Go to original source...
  36. Dattilo G, Imbalzano E, Casale M, et al. Psoriasis and Cardiovascular Risk: Correlation Between Psoriasis and Cardiovascular Functional Indices. Angiology 2018;69:31-37. Go to original source... Go to PubMed...
  37. Hutyra M, Paleček T, Hromádka M. The use of echocardiography in acute cardiovascular care. Summary of the document prepared by the Czech Society of Cardiology. Cor Vasa 2018;60:e70-e88. Go to original source...
  38. Imbalzano E, Di Bella G, Lamari A, et al. Right ventricular myocardial deformation in young healthy subjects: A comparison study between 2D Strain and traditional parameters. Experiment Clin Cardiol 2014;20:2729-2743.
  39. Lu HT, Kam J, Nordin RB, et al. Beta-blocker use and risk of symptomatic bradyarrhythmias: a hospital-based case-control study. J Geriatr Cardiol 2016;13:749-759. Go to PubMed...
  40. Yeh SJ, Yamamoto T, Lin FC, et al. Repetitive sinoatrial exit block as the major mechanism of drug-provoked long sinus or atrial pause. J Am Coll Cardiol 1991;18:587-595. Go to original source...
  41. Simonsen E, Nielsen BL, Nielsen JS. Sinus node dysfunction in acute myocardial infarction. Acta Med Scand 1980;208:463-469. Go to original source... Go to PubMed...
  42. Ha LD, Abbas F, Rao M. Guillain-Barré Syndrome Presenting with Sinus Node Dysfunction and Refractory Shock. Am J Case Rep 2017;18:251-254. Go to original source...
  43. Emmons PR, Blume WT, DuShane JW. Cardiac monitoring and demand pacemaker in Guillain-Barré syndrome. Arch Neurol 1975;32:59-61. Go to original source...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.